Does the FDA approve compounded hormones

DISCLOSURE: Voshell's Pharmacy is a licensed compounding pharmacy that prepares and sells compounded medications by prescription. As a provider of competing products, our perspective may be influenced by our professional and commercial interests.

No, the FDA does not approve compounded hormones. The FDA only approves specific, standardized hormone products made by pharmaceutical manufacturers. Compounded medications are not reviewed by FDA for safety or effectiveness before dispensing and are prepared by a licensed pharmacist only in response to a valid prescription for an individual patient.

What "not reviewed by FDA" really means

Compounded hormone preparations are prepared by a licensed pharmacist in response to a valid prescription for an individual patient. Because these preparations are produced in smaller quantities, the FDA does not evaluate them through the same pathway it uses for commercially manufactured hormone medications. This means the FDA has not reviewed them for:

• Consistency — whether each dose contains the exact amount of hormone the label states.
• Purity — whether the preparation is free of contaminants.
• Safety — whether the preparation has been tested in large clinical trials.
• Effectiveness — whether it reliably works for the intended indication.

This does not mean compounded hormone preparations automatically present harm. It means they fall outside the FDA's standard approval pathway, as noted by the FDA (FDA.gov).

Why some patients are prescribed compounded hormone preparations

There are specific clinical circumstances where a compounding pharmacy may prepare a hormone preparation, such as:

• Allergy to an ingredient found in commercially available products.
• Need for an unusual dose that commercially available products do not offer.
• Requirement for a unique dosage form that is not commercially available.

In these circumstances, a compounding pharmacy may prepare an option in response to a valid prescription for an individual patient. These situations involve a specific clinical need documented by a qualified prescriber — not a preference for compounded preparations over commercially available alternatives.

Comparing the regulatory pathways

Commercially available hormone products go through strict FDA review so there is documented evidence about how they behave in the body. Compounded hormone preparations have not gone through that same standardized review process, so there is less certainty regarding dose consistency and long-term outcomes. A qualified prescriber and careful follow-up are important when compounded preparations are used.

Key considerations

The FDA does not approve compounded hormones. Compounded preparations may be considered by a qualified prescriber in specific clinical circumstances, but they are not established as having superior safety or efficacy compared to commercially available hormone therapy. If you have questions about hormone therapy options, a licensed clinician familiar with both pathways may help you understand what is appropriate for your clinical situation.

Important note: The FDA has specifically stated that compounded hormone therapy is not equivalent to commercially manufactured hormone therapy. Major medical bodies (NAMS, ACOG, Endocrine Society) recommend commercially available hormone therapy as the first-line option when it meets patient needs. Compounded preparations are made by a licensed pharmacist only in response to a valid prescription for an individual patient.